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Stable Differences
Previous genome-wide 
gene expression studies 
identified four intrinsic gene 
expression subsets (diffuse-
proliferation, inflammatory, 
limited, and normal-like) 
among patients with systemic 
sclerosis (SSc). Pendergrass 
and colleagues confirmed 
these intrinsic subsets in 60 
skin biopsy specimens from 
22 SSc patients and 9 controls. 
Although prior studies had 
suggested that SSc pathology 
evolves from inflammatory 
to fibrotic during disease 
progression, these new 
results demonstrated that 
the classifications were 
stable over time. Therefore, 
different disease processes 
may underlie the different 
patient subsets, suggesting 
that specific treatments will 
be useful to treat different 
patients. See page 1363
Taking a Risk
To examine the association 
between nucleotide excision 
repair (NER) single-nucleotide 
polymorphisms and the 
risk of nonmelanoma skin 
cancer (NMSC), Wheless 
and colleagues performed a 
candidate pathway association 
study. Although more than 
31 NER genes have been 
implicated in this pathway, this 
analysis demonstrated that 
two tightly linked functional 
polymorphisms in one of 
these genes, ERCC6, were 
significantly associated with an 
increased risk of NMSC and, 
specifically, an increased risk 
of basal cell carcinoma. This 
finding highlights the potential 
for ERCC6 as a skin cancer risk 
factor. See page 1354
Placing the Blame
Although cutaneous disorders such as the 
photos ensitivity disorder hydroa vacciniforme 
(HV) and hypersensitivity to mosquito bites 
(HMB) are closely associated with Epstein–Barr 
virus (EBV)–infected T or natural killer (NK) cells, 
the cell type responsible for the development 
of HV remains unknown. Hirai and colleagues 
found that HV is associated with increased num-
bers of EBV-infected γδT cells in skin lesions 
without concomitant NK-cell infiltration, where-
as HMB lesions exhibited increased NK-cell 
infiltration. In addition, the γδT cells in HV patients contained higher levels of EBV 
DNA than did the non-γδT cells from these patients. These results implicate this T-cell 
subset in the pathogenesis of HV. See page 1401
Natural Gene Therapy
Previously, revertant mosaicism, which results from a 
spontaneous genetic event that corrects an inherited 
disease-causing mutation, was identified in 35% of 
patients with non-Herlitz junctional epidermolysis 
bullosa (JEB-nH) caused by mutations in COL17A or 
LAMB3. In a recent analysis of four JEB-nH patients 
with COL17A mutations, Pasmooij and colleagues 
found that the c.2237delG mutation was corrected 
by five different methods, including transition muta-
tion, a large deletion, and an indel mutation. Thus, 
no preference for a certain genetic event was found. 
Furthermore, confirmation of revertant mosaicism in 
nearly all of the generalized JEB-nH patients suggests 
future therapies involving grafting of the patient’s own 
naturally corrected keratinocytes. See page 1374
Silence the Alarmins
In psoriatic skin, the antimicrobial 
proteins psoriasin and koebnerisin act 
synergistically as chemoattractants 
and alarmins to increase inflamma-
tion via upregulation of proinflamma-
tory cytokines such as tumor necrosis 
factor-α, IL-6, and IL-8. Vitamin D 
analogs such as calcipotriol have been 
a hallmark in psoriasis treatment, but 
the mechanism of action is unknown. 
Hegyi and colleagues demonstrated 
that calcipotriol normalizes the psoriatic phenotype and suppresses T helper type 17 cyto-
kine–mediated expression of psoriasin and koebnerisin in psoriatic skin. Thus, vitamin D 
analogs interfere with the S100-mediated proinflammatory feedback loop to silence the 
alarmin molecules and clear psoriasis. See page 1416
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